Aminobutyrates
-
Subject Areas on Research
- A Novel Paradigm for Sacubitril/Valsartan: Beta-Endorphin Elevation as a Contributor to Exercise Tolerance Improvement in Rats With Preexisting Heart Failure Induced by Pressure Overload.
- Activation of metabotropic glutamate receptor 7 in spinal cord inhibits pain and hyperalgesia in a novel formalin model in sheep.
- Angiotensin receptor neprilysin inhibition in heart failure: mechanistic action and clinical impact.
- Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure.
- B-Type Natriuretic Peptide Testing in the Era of Neprilysin Inhibition: Are the Winds of Change Blowing?
- Calcium-dependent gamma-aminobutyrate release by interneurons of rat hippocampal regions: lesion-induced plasticity.
- Can 2 Pills a Day Keep Readmission Away?: Sacubitril/Valsartan to Reduce 30-Day Heart Failure Readmissions.
- Combined neprilysin and renin-angiotensin system inhibition in heart failure with reduced ejection fraction: a meta-analysis.
- Comparative proteomic analysis of differentially expressed proteins in β-aminobutyric acid enhanced Arabidopsis thaliana tolerance to simulated acid rain.
- Concurrent measurements of blood flow and transcapillary transport in xenotransplanted human gliomas in immunosuppressed rats.
- Early Adoption of Sacubitril/Valsartan for Patients With Heart Failure With Reduced Ejection Fraction: Insights From Get With the Guidelines-Heart Failure (GWTG-HF).
- Effect of glutamate analogues on brain tumor cell lines.
- GABA, picrotoxin and retinal sensitivity.
- Glutamate as transmitter of hippocampal perforant path.
- Growth inhibitory effects of aromatic fatty acids on ovarian tumor cell lines.
- High-sensitivity rod photoreceptor input to the blue-yellow color opponent pathway in macaque retina.
- LCZ696: too good to be true?
- Metabolism of the aspartyl moiety of N-acetyl-L-aspartic acid in the rat brain.
- Multifocal electroretinogram in rhodopsin P347L transgenic pigs.
- Neprilysin is a Mediator of Alternative Renin-Angiotensin-System Activation in the Murine and Human Kidney.
- Patient, Provider, and Practice Characteristics Associated With Sacubitril/Valsartan Use in the United States.
- Pharmacologically defined components of the normal porcine multifocal ERG.
- Potential Mortality Reduction With Optimal Implementation of Angiotensin Receptor Neprilysin Inhibitor Therapy in Heart Failure.
- Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial.
- Rationale and methods of the Prospective Study of Biomarkers, Symptom Improvement, and Ventricular Remodeling During Sacubitril/Valsartan Therapy for Heart Failure (PROVE-HF).
- Reply: Adoption of Sacubitril/Valsartan Must Take Into Account Different Heart Failure Patient Types.
- Scope of Sacubitril/Valsartan Eligibility After Heart Failure Hospitalization: Findings From the GWTG-HF Registry (Get With The Guidelines-Heart Failure).
- Subcellular distribution of transmitter-related enzyme activities in discrete areas of the rat dentate gyrus.
- The ABCs of managing systolic heart failure: Past, present, and future.
-
Keywords of People
- Field, Greg D., Assistant Professor of Neurobiology, Neurobiology